Chilton Capital Management LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,576 shares of the healthcare conglomerate’s stock after purchasing an additional 513 shares during the quarter. Chilton Capital Management LLC’s holdings in UnitedHealth Group were worth $848,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in UNH. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group during the second quarter worth $110,000. Kings Point Capital Management increased its stake in shares of UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group during the second quarter valued at $121,000. Institutional investors and hedge funds own 86.20% of the company’s stock.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $5.36 during mid-day trading on Tuesday, hitting $221.42. The stock had a trading volume of 5,591,400 shares, compared to its average volume of 3,118,647. UnitedHealth Group Incorporated has a 1-year low of $156.09 and a 1-year high of $231.77. The stock has a market capitalization of $213,740.00, a price-to-earnings ratio of 23.62, a price-to-earnings-growth ratio of 1.68 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.35%. UnitedHealth Group’s payout ratio is 34.09%.
In related news, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold 57,606 shares of company stock worth $11,566,525 in the last 90 days. Insiders own 0.89% of the company’s stock.
UNH has been the topic of several research reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Cantor Fitzgerald restated a “buy” rating and set a $225.00 price target on shares of UnitedHealth Group in a research note on Monday, November 27th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Piper Jaffray Companies raised their price target on UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research note on Tuesday, October 17th. Finally, Morgan Stanley raised their price target on UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Three analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and an average price target of $224.56.
WARNING: “UnitedHealth Group Incorporated (UNH) Shares Bought by Chilton Capital Management LLC” was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://www.chaffeybreeze.com/2017/12/05/unitedhealth-group-incorporated-unh-shares-bought-by-chilton-capital-management-llc.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.